The PWY.3001‐associated microbiota increases OS risk by inhibiting protective metabolites like cmpf (mediating effect of 35%), while F. plautii promotes tumor progression via CX3CR1 activation on CD14− CD16− protumor monocytes (mediating effect of 4.91%). This evidence concerns the gene CD14 and neoplasm.